On January 6, 2026, Reuters published an article entitled “Nestle recalls infant formula batches in 25 countries over toxin risk.” The article stated that Nestlé “said it was recalling some batches of its infant nutrition products, including SMA, BEBA and NAN formulas, mostly in Europe, due to possible contamination with a toxin that can cause nausea and vomiting.”
On this news, Nestlé American Depositary Shares (“ADS”) fell 1.2% on January 6, 2026, and a further 2.49% on January 7, 2026.